Trade Report: The Johnson & Johnson (JNJ) Stake Increased by Northeast Investment Management

The Johnson & Johnson (JNJ) Stake Increased by Northeast Investment Management

Northeast Investment Management raised its stake in Johnson & Johnson (NYSE:JNJ) by 0.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 248,886 shares of the company’s stock after buying an additional 1,333 shares during the period. Johnson & Johnson makes up about 3.0% of Northeast Investment Management’s portfolio, making the stock its 3rd largest position. Northeast Investment Management’s holdings in Johnson & Johnson were worth $30,190,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in JNJ. Avalon Advisors LLC increased its stake in shares of Johnson & Johnson by 32.7% in the first quarter. Avalon Advisors LLC now owns 410,880 shares of the company’s stock valued at $44,457,000 after buying an additional 101,250 shares during the last quarter. Fisher Asset Management LLC increased its stake in shares of Johnson & Johnson by 0.4% in the first quarter. Fisher Asset Management LLC now owns 10,854,263 shares of the company’s stock valued at $1,195,923,000 after buying an additional 38,299 shares during the last quarter. British Columbia Investment Management Corp increased its stake in shares of Johnson & Johnson by 1.0% in the second quarter. British Columbia Investment Management Corp now owns 1,649,232 shares of the company’s stock valued at $200,052,000 after buying an additional 17,000 shares during the last quarter. Legal & General Group Plc increased its stake in shares of Johnson & Johnson by 1.7% in the first quarter. Legal & General Group Plc now owns 13,449,262 shares of the company’s stock valued at $1,455,269,000 after buying an additional 226,357 shares during the last quarter. Finally, Investec Asset Management LTD increased its stake in shares of Johnson & Johnson by 49.2% in the first quarter. Investec Asset Management LTD now owns 5,050,411 shares of the company’s stock valued at $546,454,000 after buying an additional 1,665,644 shares during the last quarter. 65.32% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Johnson & Johnson (NYSE:JNJ) traded up 0.41% during trading on Friday, hitting $119.24. 4,799,292 shares of the stock were exchanged. Johnson & Johnson has a 12-month low of $94.12 and a 12-month high of $126.07. The stock has a market cap of $326.23 billion, a P/E ratio of 22.22 and a beta of 0.62. The stock has a 50-day moving average of $118.85 and a 200 day moving average of $117.07.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.68 by $0.06. The business earned $18.50 billion during the quarter, compared to the consensus estimate of $17.98 billion. Johnson & Johnson had a net margin of 20.97% and a return on equity of 24.70%. Equities analysts predict that Johnson & Johnson will post $6.69 earnings per share for the current fiscal year.

A number of equities research analysts have commented on JNJ shares. Zacks Investment Research downgraded shares of Johnson & Johnson from a “hold” rating to a “sell” rating in a research report on Wednesday, September 28th. Leerink Swann reissued a “buy” rating on shares of Johnson & Johnson in a research report on Sunday, September 11th. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $124.21 price objective on the stock in a research report on Monday, August 22nd. BTIG Research reissued a “neutral” rating on shares of Johnson & Johnson in a research report on Thursday, August 25th. Finally, Deutsche Bank AG reissued a “buy” rating and issued a $142.00 price objective on shares of Johnson & Johnson in a research report on Friday, August 19th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $120.19.

In other Johnson & Johnson news, VP Dominic J. Caruso sold 41,146 shares of the company’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $125.01, for a total value of $5,143,661.46. Following the completion of the sale, the vice president now directly owns 157,819 shares of the company’s stock, valued at approximately $19,728,953.19. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Ronald A. Kapusta sold 2,935 shares of the company’s stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $125.01, for a total transaction of $366,904.35. Following the completion of the sale, the chief accounting officer now directly owns 28,660 shares of the company’s stock, valued at $3,582,786.60. The disclosure for this sale can be found here. 0.11% of the stock is currently owned by corporate insiders.

About Johnson & Johnson

Related posts

Leave a Comment